Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination will affect the Food and Drug Administration.
Source link : https://www.washingtonpost.com/business/2024/11/15/rfk-jr-fda-health-care-companies-trump/
Author : Daniel Gilbert, Rachel Roubein, David Ovalle
Publish date : 2024-11-15 21:51:41
Copyright for syndicated content belongs to the linked Source.
